|
|
|
|
Publications 2009
|
- Blazkova J, Trejbalova K, Gondois-Rey F, Halfon P, Philibert P, Guiguen A, Verdin E, Olive D, Van Lint C, Hejnar J, Hirsch I (2009) CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 5:e1000554.
- Cavrois M, Neidleman JA, Greene WC. Measuring virion fusion by primary HIV envelopes. Methods. In press.
- Cho S, Schroeder S, Kaelchke K, Kwon H-S, Pedal A, Herker E, Schnoelzer M, Ott M (2009) Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells. EMBO J. 28:1407–1417.
- Cho S-Y, Schroeder S, Ott M. Cyclin meets chromatin. Cell Cycle. In press.
- Cooper HM, Huang JY, Verdin E, Spelbrink JN (2009) A new splice variant of the mouse SIRT3 gene encodes the mitochondrial precursor protein. PLoS ONE 4:e4986.
- Grant RM. Antiretroviral treatment in recently infected persons. In: Approach towards management of HIV infection and its related complications (V. Yu, ed.) Lippincott, Williams and Wilkins, Hagerstown, MD, In Press.
- Grant RM. Antiretrovirals for prevention: PrEP, PEP, and Microbicides. Curr. Inf. Dis. In Press.
- Hirschey MD, Shimazu T, Huang JY, Verdin E (2009) Chapter 8 actetylation of mitochondrial proteins. Methods Enzymol. 457:137–147.
- Hirschey MD, . . .Verdin E, et al. SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation. Nature. In press.
- Huang J-Y, Hirschey MD, Shimazu T, Ho L, Verdin E. Mitochondrial sirtuins. Biochem. Biophys. Acta. In press.
- Kauder S, Bosque A, Lindqvist A, Planelles V, Verdin E (2009) Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Path. 5:e1000495.
- Kauder S, Pagans-Lista S, Ott M, Verdin E. HIV transcription in the context of chromatin. Nat. Rev. Microbiol. In press.
- Larue RS, Andrésdóttir V, Blanchard Y, Conticello SG, Derse D, Emerman M, Greene WC, Jónsson SR, Landau NR, Löchelt M, Malik HS, Malim MH, Münk C, O'Brien SJ, Pathak VK, Strebel K, Wain-Hobson S, Yu XF, Yuhki N, Harris RS (2009) Guidelines for naming non-primate APOBEC3 genes and proteins. J. Virol. 83:494–497.
- Michel N, Goffinet C, Ganter K, Allespach I, KewalRamani VN, Saifuddin M, Littman DR, Greene WC, Goldsmith MA, Keppler OT (2009) Human Cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo. Retrovirology doi:10.1186/1742-4690-6-2.
- Mottet D, Pirotte S, Lamour V, Hagedorn M, Javerzat S, Bikfalvi A, Bellahcène A, Verdin E, Castronovo V (2009) HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene 28:243–256.
- Pagans-Lista S, Sakane N, Ott M. Specific antibodies against post-translationally modified Tat. Methods. In press.
- Pintchovski SA, Peebles CL, Kim HJ, Verdin E, Finkbeiner S (2009) The Serum Response Factor and a Putative Novel Transcription Factor Regulate Expression of the Immediate-Early Gene Arc/Arg3.1 in Neurons. J. Neurosci. 29:1525–1537.
- Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ (2009) The challenge of finding a cure for HIV infection. Science 323:1304–1307.
- Roan NR, Münch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC (2009) The cationic properties of SEVI underlie its ability to enhance HIV infection. J. Virol. 83:73–80.
- Roan NR, Sowinski S, Münch J, Kirchhoff F, Greene WC. The aminoquinoline surfen inhibits action of semen-derived enhancer of viral infection (SEVI). J Biol. Chem. In Press.
- Saunders LR, Verdin E (2009) Stress response and aging. Science 323:1021-1022.
- Schäfer S, Saunders L, Schlimme S, Valkov V, Wagner JM, Kratz F, Sippl W, Verdin E, Jung M (2009) Pyridylalanine-containing hydroxamic acids as selective HDAC6 inhibitors. Chem. Med. Chem. 4:283–290.
- Wissing S, Byers N, Greene WC. Biology of HV-1 Vif. Mol. Aspects Med. In press.
|
|
|
|
|
|
